2019 10-Q Q2

Company

CytomX Therapeutics, Inc.

Filed

August 7, 2019

Period of Report

June 30, 2019

Accession Number

0001564590-19-030054

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →